Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance

By Pebody R.G.   Gay N.J.   Hesketh L.M.   Vyse A.   Morgan-Capner P.   Brown D.W.   Litton P.   Miller E.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1134-1140

Elsevier

Access to resources Recommend Favorite

Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination

By Bautista-Lopez N.   Ward B.J.   Mills E.   McCormick D.   Martel N.   Ratnam S.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1393-1401

Elsevier

Access to resources Recommend Favorite

Familial adverse events after measles-mumps-rubella (MMR) vaccination

By Guala A.   Garipoli V.   Pastore G.   Pagani L.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 991-991

Elsevier

Access to resources Recommend Favorite

Enhanced surveillance of primary measles mumps and rubella (MMR) immunisation in Wales

By Mason B.W.   Thomas D.R.   Salmon R.L.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3635-3637

Elsevier

Access to resources Recommend Favorite

Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage

By van den Hof S.   Berbers G.A.M.   de Melker H.E.   Conyn-van Spaendonck M.A.E.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 931-940

Elsevier

Access to resources Recommend Favorite